Announcements Trials
Browse Landscape

Phase

Phase 2 53Phase 1/2 13Phase 3 12Phase 1 11Phase NA 5Phase 2/3 4

Status

Unknown 5Completed 5Terminated 3Recruiting 2Withdrawn 1

Sponsor Class

OTHER 3UNKNOWN 1INDUSTRY 1

Study Type

Interventional 5

Sponsor

Cancer Type

CNS 3Sarcoma 1

Conditions

Glioblastoma 2Recurrence 1Neoplasms 1Leiomyosarcoma 1Glioma 1

Interventions

Exercise 57Radiotherapy 49Blood Specimen Collection 45Radiosurgery 35Drug Therapy 33Standard of Care 32Surgical Procedures, Operative 30Magnetic Resonance Spectroscopy 26Laparoscopy 24Cisplatin 24Cyclophosphamide 23Biopsy 23Acupuncture Therapy 23Magnetic Resonance Imaging 20Saline Solution 19Radiofrequency Ablation 19Endoscopic Mucosal Resection 19Control Groups 19camrelizumab 16Propofol 16Metformin 16Cytarabine 16Surveys and Questionnaires 15Preoperative Exercise 15Injections 15Fluorouracil 15anlotinib 14Radiotherapy, Intensity-Modulated 14Neoadjuvant Therapy 14Early Intervention, Educational 14

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Phase NA × Unknown × Temozolomide × Clear all
NCT05204524 2022-01-24

Temozolomide for Injection Combined With Epirubicin in First-line Treatment of Leiomyosarcoma

ChineseAMS

Phase NA Unknown
28 enrolled
Sarcoma

Leiomyosarcoma

NCT03780569 2018-12-20

TTFields Together With Temozolomide and Radiotherapy in Patients With Newly Diagnosed GBM

NovoCure Ltd.

Phase NA Unknown
10 enrolled
CNS

Glioblastoma

NCT02015728 2016-12-15

SEED

Seattle Children's Hospital

Phase NA Unknown
20 enrolled

Neoplasms, Recurrence

NCT02416999 2016-02-18

Ultra-low Dose Bevacizumab Plus Temozolomide for Recurrent High-grade Gliomas

Hebei Yanda Hospital

Phase NA Unknown
30 enrolled
CNS

Glioma

NCT01939574 2016-01-21

A Explore Study of Bevacizumab Combined With Conventional Therapy in Glioblastoma

Shandong Cancer Hospital and Institute

Phase NA Unknown
20 enrolled
CNS

Glioblastoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡